SAN DIEGO – As noted in yesterday's edition of Medical Device Daily, the FDA guidance for low-glucose suspend insulin delivery systems is out and may foreshadow at least some of the content of a guidance addressing a full artificial pancreas. (Medical Device Daily) Read More
